Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis

Citation
K. Ahmadi et al., Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis, BR J RHEUM, 37(12), 1998, pp. 1330-1333
Citations number
26
Categorie Soggetti
Rheumatology
Journal title
BRITISH JOURNAL OF RHEUMATOLOGY
ISSN journal
02637103 → ACNP
Volume
37
Issue
12
Year of publication
1998
Pages
1330 - 1333
Database
ISI
SICI code
0263-7103(199812)37:12<1330:ATKPLI>2.0.ZU;2-E
Abstract
The role of microbial lipopolysaccharides (LPS) in the aetiopathogenesis of ankylosing spondylitis (AS) is a matter of continuing debate. In this stud y, class-specific IgG, IgA and IgM antibodies against Klebsiella pneumoniae , Escherichia coli, Salmonella typhimurium and Salmonella enteritidis LPS w ere measured by enzyme-linked immunosorbent assay (ELISA) in 100 AS patient s, 50 rheumatoid arthritis (RA) patients and 50 healthy control subjects. T he AS patients had significantly elevated levels of IgG and IgA antibodies against IL pneumoniae LPS (P < 0.001) and IgA antibodies against E, coli LP S (P < 0.05) compared to healthy controls. There were no significant elevat ions of antibody levels against S. typhimurium and S. enteritidis in the th ree study groups. In addition, there was a correlation between IgG and IgA anti-IL pneumoniae LPS antibody levels and the acute-phase reactant C-react ive protein (P < 0.001).